A mixed blessing for liver transplantation patients — Rapamycin

Guang-Han Fan,Chen-Zhi Zhang,Feng-Qiang Gao,Xu-Yong Wei,Sun-Bin Ling,Kai Wang,Jian-Guo Wang,Shu-Sen Zheng,Mehrdad Nikfarjam,Xiao Xu

Hepatobiliary & Pancreatic Diseases International（2023）

引用 4|浏览19

暂无评分

摘要

Rapamycin prevents HCC recurrence post LT in some patients, but it also induces metabolic disorders. Reasonable use of rapamycin benefits the liver recipients.

查看译文

关键词

Liver transplantation,Rapamycin,Metabolic disease,Hepatocellular carcinoma,Tumor recurrence

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要